Our Pricing

Mounjaro Northern Ireland - Lowest UK Prices Online

Searching for mounjaro northern ireland lowest price uk options with convenient home delivery? Cured Pharmacy offers genuine UK-licensed Mounjaro (tirzepatide) pens from £135.00 with free clinical consultations by UK prescribers and discreet next-day delivery across Northern Ireland. Our transparent upfront pricing means you'll know the exact cost before your consultation, with no hidden fees or surprise charges.

How Mounjaro Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in the UK [1]. Unlike single-pathway treatments, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, producing enhanced effects on appetite regulation, insulin secretion, and energy expenditure.

In the landmark SURMOUNT-1 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks — the highest weight loss observed in any obesity medication trial to date [1]. Patients typically experience reduced hunger, increased satiety after meals, and improved glycaemic control. The medication works by slowing gastric emptying and acting on brain regions that regulate appetite, helping you feel fuller for longer between meals.

Clinical data shows that tirzepatide produces dose-dependent weight loss, with higher doses generally associated with greater reductions in body weight [2]. Your UK prescriber will determine the appropriate starting dose and titration schedule based on your individual medical history, current medications, and weight loss goals.

Mounjaro Northern Ireland Lowest Price UK: What You Pay at Cured Pharmacy

At Cured Pharmacy, Mounjaro starts from £135.00 for UK patients including those in Northern Ireland, with transparent pricing displayed before you begin your consultation. This represents competitive UK pricing compared to typical market rates, and we guarantee you're getting the lowest prices available from a registered UK pharmacy.

Your final cost depends on the prescribed dose strength determined by your UK prescriber during your free clinical assessment. All Mounjaro pens are genuine UK-licensed medication sourced directly from authorised wholesalers, never grey-market imports. We include discreet packaging and tracked delivery across Northern Ireland at no additional charge, with most orders arriving within 24-48 hours of prescriber approval.

Unlike some online services that advertise low headline prices but add consultation fees, delivery charges, or subscription commitments, our pricing is completely transparent. The price you see is the price you pay, with no hidden costs or mandatory ongoing subscriptions. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) personally oversees all dispensing to ensure every patient receives authentic medication with full safety checks.

Northern Ireland Delivery and Prescribing

As a UK-registered online pharmacy (GPhC 9012511), Cured Pharmacy serves patients throughout Northern Ireland with the same clinical standards and regulatory oversight as any high-street pharmacy. Your online consultation is conducted by UK-registered prescribers who assess your suitability for Mounjaro based on NICE guidelines and MHRA licensing criteria, typically reviewing your medical history, current BMI, previous weight loss attempts, and any contraindications.

Once approved, your prescription is dispensed by our UK-based pharmacy team and shipped via Royal Mail tracked service in fully discreet packaging. Most Northern Ireland deliveries arrive within 1-2 working days, and you'll receive tracking information to monitor your parcel's progress.

Mounjaro vs Wegovy: Comparing Weight Loss Injections

Both Mounjaro and Wegovy are once-weekly injectable medications licensed in the UK for chronic weight management, but they work through different mechanisms with distinct clinical profiles. Wegovy contains semaglutide, a single GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, which activates both GLP-1 and GIP receptors simultaneously [1][3].

Head-to-head trial data from the SURPASS-2 study showed that tirzepatide produced significantly greater weight loss than semaglutide at comparable doses, with the 15mg tirzepatide group achieving approximately 5.5kg more weight loss on average than the 1mg semaglutide group over 40 weeks [2]. However, both medications demonstrate robust efficacy, and individual response varies considerably between patients.

The choice between Mounjaro and Wegovy often comes down to individual tolerability, medical history, and prescriber recommendation. Some patients find one medication easier to tolerate than the other in terms of gastrointestinal side effects. Your UK prescriber will discuss which option may be most suitable based on your specific circumstances, previous treatment responses, and any relevant medical conditions.

Side Effect Profiles and Tolerability

Both medications share similar side effect profiles, with nausea, diarrhoea, constipation, and abdominal discomfort being the most commonly reported adverse events [1][3]. These gastrointestinal symptoms typically occur during dose escalation and often diminish over time as your body adjusts to the medication. Starting at a lower dose and gradually increasing helps minimise these effects.

Serious side effects are rare but can include pancreatitis, gallbladder problems, and hypoglycaemia (particularly in patients taking other diabetes medications). Your prescriber will review contraindications including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 before prescribing either medication.

Clinical Evidence: SURMOUNT and SURPASS Trials

The efficacy of Mounjaro for weight management is supported by the extensive SURMOUNT clinical trial programme, which enrolled over 5,000 adults with obesity or overweight across multiple international sites [1]. SURMOUNT-1, the pivotal phase 3 trial, demonstrated that 91% of participants on the 15mg dose achieved at least 5% body weight reduction, with 57% achieving at least 20% weight loss over 72 weeks.

Secondary endpoints showed significant improvements in cardiometabolic risk factors including waist circumference reduction (average 18.5cm at highest dose), improvements in systolic blood pressure (average reduction of 7.4mmHg), and favourable changes in lipid profiles [1]. These cardiovascular benefits are particularly relevant for patients with obesity-related comorbidities.

The SURPASS trial programme, whilst primarily focused on type 2 diabetes management, provided additional evidence of tirzepatide's weight loss effects in patients with diabetes [2]. SURPASS-3 compared tirzepatide directly against insulin degludec in patients with inadequately controlled type 2 diabetes, showing superior glycaemic control and substantial weight loss with tirzepatide versus weight gain typically seen with basal insulin therapy.

Who Can Use Mounjaro in Northern Ireland

Mounjaro is licensed in the UK for adults with an initial BMI of 30 kg/m² or greater (obesity), or 27 kg/m² or greater (overweight) in the presence of at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidaemia [4]. NICE guidance recommends GLP-1 receptor agonists as part of a comprehensive weight management programme including dietary modification and increased physical activity.

During your online consultation, the UK prescriber will assess your eligibility by reviewing your medical history, current medications, BMI calculation, previous weight loss attempts, and any contraindications. Mounjaro is not suitable for everyone — it's contraindicated in pregnancy, breastfeeding, patients under 18 years, those with a personal or family history of medullary thyroid carcinoma, and individuals with multiple endocrine neoplasia syndrome type 2.

The prescriber will also evaluate potential drug interactions, particularly with other diabetes medications that may increase hypoglycaemia risk when combined with tirzepatide. If Mounjaro isn't appropriate for your circumstances, alternative weight management options such as Wegovy, Saxenda, or oral medications like Orlistat may be more suitable, and your prescriber will discuss these alternatives during the consultation.

Lifestyle Modifications Alongside Mounjaro

Mounjaro is most effective when used as part of a comprehensive weight management programme that includes reduced-calorie diet and increased physical activity [1]. Clinical trials enrolled participants who received lifestyle intervention counselling alongside medication, and real-world effectiveness depends on sustainable behavioural changes.

Your prescriber may recommend working with a dietitian or weight management service to optimise your nutrition plan, aiming for a calorie deficit that supports gradual, sustainable weight loss. Regular physical activity — aiming for at least 150 minutes of moderate-intensity exercise weekly — enhances weight loss outcomes and provides cardiovascular benefits independent of weight reduction.

How to Order Mounjaro from Cured Pharmacy

Ordering Mounjaro for delivery to Northern Ireland takes less than three minutes through our streamlined online consultation process. Start by clicking the 'Start Assessment' button, which takes you to a brief medical questionnaire covering your weight history, current health conditions, medications, and lifestyle factors. This information is reviewed by a UK-registered prescriber, typically within a few hours during working days.

If the prescriber approves your request, they'll issue an electronic prescription which is immediately sent to our dispensing team. We'll process your order the same day if approved before our cut-off time (typically 3pm on working days), with your medication dispatched via Royal Mail tracked delivery in plain, discreet packaging with no external markings indicating the contents.

You'll receive email updates at each stage — consultation submitted, prescription approved, order dispatched, and tracking information. Most Northern Ireland addresses receive delivery within 1-2 working days. If the prescriber determines Mounjaro isn't suitable based on your medical history, they'll explain why and may suggest alternative treatments that better match your clinical needs. There's no obligation to proceed if you're not approved, and our clinical team is available on (+44) 116 4646009 if you have questions about the process.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-218. https://doi.org/10.1056/NEJMoa2206038
2. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. https://doi.org/10.1056/NEJMoa2107519
3. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & STEP 1 Study Group. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183
4. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating overweight and obesity [TA1026]. NICE. https://www.nice.org.uk/guidance/ta1026

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro is a prescription-only medicine and individual results may vary. Side effects can occur — read the patient information leaflet carefully and report any concerns to your prescriber or pharmacist.